[{"NetIncomeLossConverted_1_Q1_USD":1115200000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":105400000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":668500000.0,"EarningsPerShareDiluted_1_Q1_USD":10.09,"StockholdersEquity_0_Q1_USD":11977000000.0,"RevenuesConverted_1_Q1_USD":2528700000.0,"Assets_0_Q1_USD":17772200000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":110500000.0,"EarningsPerShareBasic_1_Q1_USD":10.58,"Ticker":"REGN","CIK":"872589","name":"REGENERON PHARMACEUTICALS, INC.","OfficialName":"Regeneron Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"77738004554.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20210506"}]